Retatrutide Peptide

Retatrutide: A Premium Research Peptide

Přehled
Retatrutide (LY3437943) is an innovative research peptide that has gained considerable attention among scientists and researchers in the UK and worldwide. This unique triagonist peptide is recognized for its potential in řízení hmotnosti, diabetes research, metabolic functiona glucose control. By targeting three essential metabolic receptors, retatrutide is paving the way for advancements in understanding and treating obesity and related metabolic disorders.

Mechanismus působení
Retatrutide simultaneously binds and activates the following three metabolic receptors:
– Glucagon-like peptide-1 (GLP-1): Enhances satiety, reduces appetite, and promotes insulin secretion.
– Glucose-dependent insulinotropic polypeptide (GIP): Facilitates improved insulin sensitivity and secretion.
– Glucagon: Increases energy expenditure and metabolism, effectively mobilizing fat stores.

This multi-faceted approach allows retatrutide to significantly enhance weight loss, improve insulin sensitivity, and boost metabolic function, making it a prime candidate for research.

Pokyny pro dávkování
While dosage recommendations for retatrutide in clinical settings are still being established, recent clinical trials have indicated the following doses for study participants:
– 8 mg/week and 12 mg/week: Indicated significant weight loss with 100% of subjects experiencing positive results.
– Initial dosing: Starting with a lower dose like 2 mg/week instead of 4 mg/week can help mitigate mild to moderate gastrointestinal side effects.

Key Benefits of Retatrutide
– Potent Weight Management: Demonstrated efficacy in sustained weight loss.
– Improved Glucose Control: Addressing insulin sensitivity and contributing to diabetes management.
– Enhanced Metabolic Function: Boosts metabolic health by increasing energy expenditure.

Audience for Retatrutide
Retatrutide is intended strictly for qualified scientific researchers and healthcare professionals engaged in metabolic research. It is not approved for human consumption outside of ethically controlled clinical trials.

Important Safety and Compliance Information
– Retatrutide is supplied for in vitro laboratory research purposes pouze.
– Not approved by regulatory authorities for human or veterinary use.
– Researchers must adhere to all relevant local regulations and ethical standards.

Chemical and Identification Data
– Molecular formula: C221H342N46O68
– Molecular weight: 4860 g/mol
– CAS number: 2381089-83-2
– PubChem CID: 171390338
– DrugBank ID: DB18993

Storage Recommendations
– Podmínky skladování: Store in a cool, dry place, away from direct sunlight.
– Temperature: Maintain between 2°C and 8°C.
– Trvanlivost: Under optimal conditions, retatrutide remains stable and potent for research use.

Available Options
Retatrutide is available in:
– 5 mg
– 10 mg

Why Purchase from UK SARMs?
– High Purity: Tested at 99.55% purity via third-party laboratories.
– Research Excellence: Manufactured to the highest standards and rigorously tested.
– Competitive Pricing: Bulk orders attract favorable pricing structures.

Purchase Assurance
– Fast and discreet shipping
– Comprehensive customer support
– Superior quality assurance

Závěr
If you’re in search of high-quality retatrutide for research purposes, UK SARMs is the trusted provider to meet your needs. With its promising potential in metabolic research and stringent quality controls, retatrutide is a leading choice for advancing scientific inquiry into obesity and diabetes.